Natural Products
| Catalog No. | Information |
| CFN95170 | Momordicoside X Momordicoside X displays moderate insulin secretion activity. |
| CFN95171 | 1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one Reference standards. |
| CFN95172 | ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid Reference standards. |
| CFN95173 | Licoricesaponin H2 Reference standards. |
| CFN91123 | Cassiaside B Reference standards. |
| CFN95174 | Marginatoxin Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway. |
| CFN91124 | Chrysophanol 1-O-beta-tetraglucoside Reference standards. |
| CFN91125 | Emodin-1-O-beta-gentiobioside Reference standards. |
| CFN91126 | 11-Oxomogroside IV Reference standards. |
| CFN91127 | N-(p-Coumaroyl) serotonin N-(p-Coumaroyl) serotonin has antioxidant, cardioprotective effects after ischemia and antitumor activity, it may be beneficial in improving vascular distensibility and in reducing cardiovascular risk.N-(p-Coumaroyl) serotonin has a suppressive effect on proinflammatory cytokine production from monocytes, and this effect is based in part on the suppression of cytokine mRNA expression through inhibition of NF-kappaB activation. |
| CFN95175 | Polygalin J Reference standards. |
| CFN95176 | Polygalasaponin XXXV Reference standards. |
| CFN91128 | 5'''-O-Feruloyl complanatoside B Reference standards. |
| CFN95177 | Pueroside A Reference standards. |
| CFN91129 | Quercetin 3-O-sophoroside-7-O-rhamnoside Reference standards. |
| CFN91130 | Isorhamnetin 3,7-O-diglucoside Isorhamnetin 3,7-O-diglucoside may have antioxidant activity. |
| CFN91131 | Hydroxy-alpha-sanshool Hydroxy-alpha-sanshool exerts antiobesity and hypolipidemic activities in HFD rats by reducing liver oxidative stress and thus could be considered as a potential candidate drug to cure or prevent obesity and hyperlipidemia. It also has analgesic properties, it activates TRPV1 and TRPA1 in sensory neurons. |
| CFN91132 | Anemarrhenasaponin III Reference standards. |
| CFN91133 | Aegeline Aegeline has anti-diabetic and anti-dyslipidemic activities, it inspired synthesis of novel amino alcohol and thiazolidinedione hybrids with antiadipogenic activity in 3T3-L1 cells, it also inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance. Aegeline mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast. |
| CFN91134 | Cassiaside B2 Reference standards. |
| CFN95178 | Citrusin B Citrusin B exhibits moderate in vitro inhibitory effect on tobacco mosaic virus replication with IC₅₀ values 0.26 mmol L⁻1. |
| CFN95179 | Yuanhunine Reference standards. |
| CFN95180 | Isonardosinone Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF-κB- and MAPK-mediated inflammatory pathways. |
| CFN95181 | New compound 2 Reference standards. |
| CFN95182 | Tessaric acid Tessaric acid has antifeedant and allelochemical effects. Tessaric acid derivatives induce G/M cell cycle arrest in human solid tumor cell lines. |
| CFN95183 | Pterodonoic acid Reference standards. |
| CFN91135 | Caulophyllogenin Caulophyllogenin in the inhibition of pro-inflammatory cytokine secretion, including IL-12 p40, IL-6, and TNF-α, and for prevention and treatment of inflammatory diseases. |
| CFN91136 | Harmidol hydrochloride Reference standards. |
| CFN91137 | N-trans-Sinapoyltyramine Reference standards. |
| CFN91138 | Randialic acid B Randialic acid B shows significant cell-protective effects against H2O2-induced H9c2 cardiomyocyte injury. |
| CFN91139 | Sanguisorbigenin Reference standards. |
| CFN91140 | Benzoylgomisin P Reference standards. |
| CFN91141 | Hythiemoside B Reference standards. |
| CFN91142 | Notoginsenoside R4 Reference standards. |
| CFN95184 | New compound 3 Reference standards. |
| CFN95185 | New compound 4 Reference standards. |
| CFN95186 | Bergaptol-beta-glucopyranoside Reference standards. |
| CFN95187 | Astin A Astin A has antitumor activity. |
| CFN95188 | Astin B Astin B has antitumor activity. |
| CFN95189 | Astin C Astin C has antitumor activity. |
| CFN95190 | Neochlorogenic acid methyl ester Neochlorogenic acid methyl ester shows anti-HBV, antioxidant and quinone reductase-inducing activities. |
| CFN95191 | (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate Reference standards. |
| CFN91143 | Silyamandin Silyamandin may have antihepatotoxic and chemopreventive activities. |
| CFN91144 | 4H-1-Benzopyran-4-one,2,3-dihydro-5-hydroxy-3-[(4-hydroxyphenyl)methyl]-7-methoxy- Reference standards. |
| CFN91145 | (+)-Delta-Tocopherol (+)-Delta-Tocopherol has antioxidant activity. |
| CFN91146 | 6-Hydroxykaempferol 3-O-beta-D-glucoside 6-Hydroxykaempferol 3-O-beta-D-glucoside has anti-thrombotic,and antioxidative activities. |
| CFN91147 | 6-Hydroxykaempferol 3-beta-rutinoside Reference standards. |
| CFN91148 | Quercetin 3-O-neohesperidoside Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities. |
| CFN91149 | Quercetin 3-O-rutinoside-(1->2)-O-rhamnoside [Quercetin-3-O-(2G-alpha-L-rhamnosyl)-rutinoside] Quercetin 3-O-rutinoside-(1→2)-O-rhamnoside shows α-glucosidase inhibitory activity, it has anti-diabetic potential. |
| CFN91150 | Syringetin-3-O-rutinoside Reference standards. |
